NACDS and NCPA speak out at FDA hearing in favor of BTC classification FDA panel hears arguments in BTC debate Amgen hit with subpoenas from U.S. attorneys seeking documents Looming drug pedigree requirements lend urgent tone to RFID conference Reverse-payment bill held up in Congress by pharmaceutical lobbying NACDS supports letter from Texas, Louisiana Congressmen to CMS administrator Cephalon submits application to FDA for supplemental uses of Fentora NACDS announces retirement of Mary Ann Wagner Will debate pull the plug on $659M in pediatric OTCs? Federal substance abuse group offers unique suggestion for disposing of medication First Previous 637 638 639 640 641 Next Last
